OGEN Stock Alert: 14 Things to Know About Oragenics as Shares Rocket ThursdayInvestorPlace • 01/07/21
Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine AdjuvantBusiness Wire • 01/07/21
CORRECTING AND REPLACING Oragenics Announces Proposed Underwritten Public OfferingBusiness Wire • 11/19/20
FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 VaccineBusiness Wire • 10/06/20
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus VaccineBusiness Wire • 08/20/20
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing AntibodiesBusiness Wire • 07/22/20